[HTML][HTML] Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis
RB Mrid, N Bouchmaa, H Ainani, R El Fatimy… - Biomedicine & …, 2022 - Elsevier
Rheumatoid arthritis (RA) is one of more than 100 types of arthritis. This chronic autoimmune
disorder affects the lining of synovial joints in about 0.5% of people and may induce severe …
disorder affects the lining of synovial joints in about 0.5% of people and may induce severe …
Tuberculosis and biologic therapies: anti-tumor necrosis factor-α and beyond
MS Godfrey, LN Friedman - Clinics in chest medicine, 2019 - chestmed.theclinics.com
Tumor necrosis factor-alpha (TNF-a) is involved in the pathogenesis of several inflammatory
diseases such as rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, and …
diseases such as rheumatoid arthritis (RA), ankylosing spondylitis, psoriatic arthritis, and …
Interleukin-1 blockade in cardiac sarcoidosis: study design of the multimodality assessment of granulomas in cardiac sarcoidosis: Anakinra Randomized Trial (MAGiC …
J Kron, T Crawford, V Mihalick, F Bogun… - Journal of Translational …, 2021 - Springer
Background Sarcoidosis is an inflammatory disease characterized by the formation of
granulomas, which involve the heart in up to 25% of patients. Cardiac sarcoidosis can lead …
granulomas, which involve the heart in up to 25% of patients. Cardiac sarcoidosis can lead …
Systemic rheumatic diseases: from biological agents to small molecules
P Sarzi-Puttini, A Ceribelli, D Marotto, A Batticciotto… - Autoimmunity …, 2019 - Elsevier
The development of biologics and small oral molecules has recently changed the scenario
of pharmacologic treatment of systemic rheumatic diseases and it has become a real …
of pharmacologic treatment of systemic rheumatic diseases and it has become a real …
The diversity outbred mouse population is an improved animal model of vaccination against tuberculosis that reflects heterogeneity of protection
Many studies of Mycobacterium tuberculosis infection and immunity have used mouse
models. However, outcomes of vaccination and challenge with M. tuberculosis in inbred …
models. However, outcomes of vaccination and challenge with M. tuberculosis in inbred …
Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task
G Ni, L Zhang, X Yang, H Li, B Ma… - Human vaccines & …, 2020 - Taylor & Francis
ABSTRACT Interleukin 10 (IL-10) belongs to IL-10 family cytokines that are critical for
maintaining the integrity of epithelial tissues, protecting pathogenic infection, and preventing …
maintaining the integrity of epithelial tissues, protecting pathogenic infection, and preventing …
[HTML][HTML] Paradoxical reactions to biologicals in chronic inflammatory systemic diseases
I Kremenevski, O Sander, M Sticherling… - Deutsches Ärzteblatt …, 2022 - ncbi.nlm.nih.gov
Background Biological agents that contain substances affecting the immune system are
increasingly being used to treat chronic inflammatory systemic diseases. Aside from the …
increasingly being used to treat chronic inflammatory systemic diseases. Aside from the …
Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists
G Fromm, S de Silva, TH Schreiber - Frontiers in Immunology, 2023 - frontiersin.org
The extracellular domain of tumor necrosis factor receptors (TNFR) generally require
assembly into a homotrimeric quaternary structure as a prerequisite for initiation of signaling …
assembly into a homotrimeric quaternary structure as a prerequisite for initiation of signaling …
Treatment of Parkinson's disease with biologics that penetrate the blood–brain barrier via receptor-mediated transport
WM Pardridge - Frontiers in Aging Neuroscience, 2023 - frontiersin.org
Parkinson's disease (PD) is characterized by neurodegeneration of nigral-striatal neurons in
parallel with the formation of intra-neuronal α-synuclein aggregates, and these processes …
parallel with the formation of intra-neuronal α-synuclein aggregates, and these processes …
Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (Chiloscyllium plagiosum)
L Zhao, M Chen, X Wang, S Kang, W Xue, Z Li - Marine Drugs, 2022 - mdpi.com
Tumor necrosis factor α (TNFα), an important clinical testing factor and drug target, can
trigger serious autoimmune diseases and inflammation. Thus, the TNFα antibodies have …
trigger serious autoimmune diseases and inflammation. Thus, the TNFα antibodies have …